Production of new flu vaccine each year shows it should be possible to adapt to coronavirus variants if necessary

The technology exists to rapidly tweak vaccines in the face of new coronavirus mutations. But it would take time, and a global strategy is needed to ensure that scientists stay one step ahead.

The emergence of more transmissible variants of Sars-CoV-2 has prompted debate over whether the vaccines developed to date will continue to give protection. Although there is little evidence to suggest this is an issue with the variants detected in the UK, South Africa and Brazil, immunologists fear further mutations.

Continue reading…

You May Also Like

The Guardian view on the cladding scandal: tough talk must be matched with substance | Editorial

Michael Gove’s admission of failures is welcome, but leaseholders need certainty they…

X marks the spot: the many fellow fans of Elon Musk’s favourite letter

From The X-Files to X-Men, Xbox to Xerox, X is loved by…

Faithless Tories feign loyalty to Rish! with all the plausibility of a Nadine Dorries story

After Simon Clarke proposed yet another leadership switch, most Tory MPs looked…

The Great British Art Tour: a crystalline cave to dazzle and unsettle

With public art collections closed we are bringing the art to you,…